Many previous studies have shown that JQ1 induces cytotoxicity in a variety of cancers (e.g., multiple myeloma, leukemia, breast cancer, and prostate cancer) due to binding to BRD4 and preventing its interaction with several oncogenes [10, 13–15]. Here, BRD4 is linked to prostate cancer.